<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 05/17/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://bioadaptives.com/role/Cover" xlink:href="bdpt-20240331.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/ConsolidatedBalanceSheets" xlink:href="bdpt-20240331.xsd#ConsolidatedBalanceSheets" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="bdpt-20240331.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" xlink:href="bdpt-20240331.xsd#ConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/ConsolidatedStatementOfStockholdersDeficitUnaudited" xlink:href="bdpt-20240331.xsd#ConsolidatedStatementOfStockholdersDeficitUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/ConsolidatedStatementsOfCashFlowUnaudited" xlink:href="bdpt-20240331.xsd#ConsolidatedStatementsOfCashFlowUnaudited" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/DescriptionOfBusinessAndHistory" xlink:href="bdpt-20240331.xsd#DescriptionOfBusinessAndHistory" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/SummaryOfSignificantPolicies" xlink:href="bdpt-20240331.xsd#SummaryOfSignificantPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/GoingConcern" xlink:href="bdpt-20240331.xsd#GoingConcern" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="bdpt-20240331.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/ConvertibleNotes" xlink:href="bdpt-20240331.xsd#ConvertibleNotes" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/DerivativeLiabilities" xlink:href="bdpt-20240331.xsd#DerivativeLiabilities" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/StockholdersEquity" xlink:href="bdpt-20240331.xsd#StockholdersEquity" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/RelatedPartyTransactions" xlink:href="bdpt-20240331.xsd#RelatedPartyTransactions" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/LicenseAndPatent" xlink:href="bdpt-20240331.xsd#LicenseAndPatent" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/CommitmentsAndContingencies" xlink:href="bdpt-20240331.xsd#CommitmentsAndContingencies" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/SubsequentEvents" xlink:href="bdpt-20240331.xsd#SubsequentEvents" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/SummaryOfSignificantPoliciesPolicies" xlink:href="bdpt-20240331.xsd#SummaryOfSignificantPoliciesPolicies" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/SummaryOfSignificantPoliciesTables" xlink:href="bdpt-20240331.xsd#SummaryOfSignificantPoliciesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="bdpt-20240331.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/ConvertibleNotesTables" xlink:href="bdpt-20240331.xsd#ConvertibleNotesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/DerivativeLiabilitiesTables" xlink:href="bdpt-20240331.xsd#DerivativeLiabilitiesTables" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/StockholdersEquityTables" xlink:href="bdpt-20240331.xsd#StockholdersEquityTables" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/LicenseAndPatentTables" xlink:href="bdpt-20240331.xsd#LicenseAndPatentTables" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/SummaryOfSignificantPoliciesDetails" xlink:href="bdpt-20240331.xsd#SummaryOfSignificantPoliciesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/GoingConcernDetailsNarrative" xlink:href="bdpt-20240331.xsd#GoingConcernDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:href="bdpt-20240331.xsd#AccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/ConvertibleNotesDetails" xlink:href="bdpt-20240331.xsd#ConvertibleNotesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/ConvertibleNotesDetailsNarrative" xlink:href="bdpt-20240331.xsd#ConvertibleNotesDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/DerivativeLiabilitiesDetails" xlink:href="bdpt-20240331.xsd#DerivativeLiabilitiesDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/DerivativeLiabilitiesDetails1" xlink:href="bdpt-20240331.xsd#DerivativeLiabilitiesDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/DerivativeLiabilitiesDetails2" xlink:href="bdpt-20240331.xsd#DerivativeLiabilitiesDetails2" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/StockholdersEquityDetails" xlink:href="bdpt-20240331.xsd#StockholdersEquityDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/StockholdersEquityDetailsNarrative" xlink:href="bdpt-20240331.xsd#StockholdersEquityDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="bdpt-20240331.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/LicenseAndPatentDetails" xlink:href="bdpt-20240331.xsd#LicenseAndPatentDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/LicenseAndPatentDetails1" xlink:href="bdpt-20240331.xsd#LicenseAndPatentDetails1" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/LicenseAndPatentDetailsNarrative" xlink:href="bdpt-20240331.xsd#LicenseAndPatentDetailsNarrative" xlink:type="simple" />
  <link:roleRef roleURI="http://bioadaptives.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="bdpt-20240331.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/ConsolidatedBalanceSheets" xlink:title="000002 - Statement - CONSOLIDATED BALANCE SHEETS">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
    <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SecurityDeposit" xlink:label="loc_us-gaapSecurityDeposit" />
    <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapSecurityDeposit" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
    <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
    <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IndefiniteLivedLicenseAgreements" xlink:label="loc_us-gaapIndefiniteLivedLicenseAgreements" />
    <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIndefiniteLivedLicenseAgreements" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent" />
    <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent" />
    <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="bdpt-20240331.xsd#bdpt_NotesPayableRelatedPartiesClassifiedAsCurrent" xlink:label="loc_bdptNotesPayableRelatedPartiesClassifiedAsCurrent" />
    <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_bdptNotesPayableRelatedPartiesClassifiedAsCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
    <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
    <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
    <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
    <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
    <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
    <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
    <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/ConsolidatedStatementsOfOperationsAndComprehensiveLossUnaudited" xlink:title="000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
    <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue" />
    <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
    <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees" />
    <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
    <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
    <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
    <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
    <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
    <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
    <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
    <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" />
    <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/ConsolidatedStatementOfStockholdersDeficitUnaudited" xlink:title="000005 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS DEFICIT (UNAUDITED)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/ConsolidatedStatementsOfCashFlowUnaudited" xlink:title="000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOW (UNAUDITED)">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
    <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
    <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
    <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
    <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" />
    <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapMarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
    <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInDueToRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInDueToRelatedParties" />
    <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDueToRelatedParties" xlink:type="arc" weight="1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
    <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/DescriptionOfBusinessAndHistory" xlink:title="000007 - Disclosure - DESCRIPTION OF BUSINESS AND HISTORY" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/SummaryOfSignificantPolicies" xlink:title="000008 - Disclosure - SUMMARY OF SIGNIFICANT POLICIES" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/GoingConcern" xlink:title="000009 - Disclosure - GOING CONCERN" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="000010 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/ConvertibleNotes" xlink:title="000011 - Disclosure - CONVERTIBLE NOTES" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/DerivativeLiabilities" xlink:title="000012 - Disclosure - DERIVATIVE LIABILITIES" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/StockholdersEquity" xlink:title="000013 - Disclosure - STOCKHOLDERS EQUITY" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/RelatedPartyTransactions" xlink:title="000014 - Disclosure - RELATED PARTY TRANSACTIONS" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/LicenseAndPatent" xlink:title="000015 - Disclosure - LICENSE AND PATENT" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/CommitmentsAndContingencies" xlink:title="000016 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/SubsequentEvents" xlink:title="000017 - Disclosure - SUBSEQUENT EVENTS" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/SummaryOfSignificantPoliciesPolicies" xlink:title="000018 - Disclosure - SUMMARY OF SIGNIFICANT POLICIES (Policies)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/SummaryOfSignificantPoliciesTables" xlink:title="000019 - Disclosure - SUMMARY OF SIGNIFICANT POLICIES (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="000020 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/ConvertibleNotesTables" xlink:title="000021 - Disclosure - CONVERTIBLE NOTES (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/DerivativeLiabilitiesTables" xlink:title="000022 - Disclosure - DERIVATIVE LIABILITIES (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/StockholdersEquityTables" xlink:title="000023 - Disclosure - STOCKHOLDERS EQUITY (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/LicenseAndPatentTables" xlink:title="000024 - Disclosure - LICENSE AND PATENT (Tables)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/SummaryOfSignificantPoliciesDetails" xlink:title="000025 - Disclosure - SUMMARY OF SIGNIFICANT POLICIES (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/GoingConcernDetailsNarrative" xlink:title="000026 - Disclosure - GOING CONCERN (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/AccountsPayableAndAccruedLiabilitiesDetails" xlink:title="000027 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/ConvertibleNotesDetails" xlink:title="000028 - Disclosure - CONVERTIBLE NOTES (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/ConvertibleNotesDetailsNarrative" xlink:title="000029 - Disclosure - CONVERTIBLE NOTES (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/DerivativeLiabilitiesDetails" xlink:title="000030 - Disclosure - DERIVATIVE LIABILITIES (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/DerivativeLiabilitiesDetails1" xlink:title="000031 - Disclosure - DERIVATIVE LIABILITIES (Details 1)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/DerivativeLiabilitiesDetails2" xlink:title="000032 - Disclosure - DERIVATIVE LIABILITIES (Details 2)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/StockholdersEquityDetails" xlink:title="000033 - Disclosure - STOCKHOLDERS EQUITY (Details)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/StockholdersEquityDetailsNarrative" xlink:title="000034 - Disclosure - STOCKHOLDERS EQUITY (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="000035 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/LicenseAndPatentDetails" xlink:title="000036 - Disclosure - LICENSE AND PATENT (Details )" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/LicenseAndPatentDetails1" xlink:title="000037 - Disclosure - LICENSE AND PATENT (Details 1 )" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/LicenseAndPatentDetailsNarrative" xlink:title="000038 - Disclosure - LICENSE AND PATENT (Details Narrative)" />
  <link:calculationLink xlink:type="extended" xlink:role="http://bioadaptives.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="000039 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
</link:linkbase>
